Chugai Pharmaceutical has been selected as a recipient of the Porter Prize 2026. Business scholar Kusunoki Ken (楠木建) described the company as “a company with an unusually interesting strategy for the pharmaceutical industry.”
Chugai Pharmaceutical has been selected as a recipient of the Porter Prize 2026, which recognizes companies that execute distinctive strategies. Kusunoki Ken (楠木建), who also serves on the prize's organizing committee, praised Chugai Pharmaceutical's strategy.
His assessment was based on the view that Chugai Pharmaceutical has strength that is difficult for competitors to imitate, suggesting that the company's strategy is attracting attention within the industry.
The article is positioned as part of a feature on Chugai Pharmaceutical's “unconventional management,” centered on the company's receipt of the award.